Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
Current Value
$7.471 Year Return
Current Value
$7.471 Year Return
Market Cap
$261.10M
P/E Ratio
118.96
1Y Stock Return
-4.58%
1Y Revenue Growth
4.88%
Dividend Yield
0.00%
Price to Book
-55.6
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The Fund returned approximately +15% in the third quarter, bringing year-to-date returns to approximately +12% net. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024. Greenhaven […]
Yahoo
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the company’s president and chief executive officer, will be a featured speaker in a fireside chat at the upcoming Stephens Annual Investment Conference. The conference is being held November 19-21, 2024, in Nashville, Tennessee. Details regarding Lifecore’s participation are as
Yahoo
Key Insights Significant control over Lifecore Biomedical by retail investors implies that the general public has more...
SeekingAlpha
Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional capital required. Click to read.
SeekingAlpha
Greenhaven Road Capital Fund returned approximately +15% net during the third quarter, bringing year-to-date returns to approximately +12% net. Read more here.
Yahoo
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will host a virtual investor day on Thursday, November 21, 2024, prior to market open. The event will take place from 8:00 – 9:30 a.m. Eastern Time and be available via webcast. During the event, members of Lifecore’s senior management team will discuss the company’s business and strategy f
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALAB | -27.47% | $15.10B | +164.39% | 0.00% |
LITB | -18.34% | $35.48M | -75.45% | 0.00% |
RNR | -12.01% | $13.74B | +23.09% | 0.58% |
BEST | -11.96% | $31.65M | +3.88% | 0.00% |
ARC | -11.74% | $146.66M | +18.95% | 5.90% |
STG | -11.74% | $35.67M | +7.92% | 0.00% |
CME | -11.64% | $82.76B | +9.21% | 1.98% |
MCK | -10.53% | $78.15B | +35.51% | 0.42% |
TCTM | -10.52% | $8.10M | -42.99% | 0.00% |
VHC | -10.49% | $19.06M | -38.36% | 0.00% |
CMG | -9.90% | $80.02B | +33.62% | 0.00% |
SPR | -9.50% | $3.72B | +23.27% | 0.00% |
MSDL | -8.96% | $1.83B | +0.66% | 7.26% |
OPTN | -8.69% | $51.10M | -72.23% | 0.00% |
CBOE | -8.26% | $21.46B | +15.84% | 1.11% |
ACGL | -7.99% | $36.00B | +16.84% | 0.00% |
COR | -7.99% | $47.48B | +21.20% | 0.86% |
NNE | -7.97% | $833.66M | +531.50% | 0.00% |
APD | -7.32% | $72.92B | +18.69% | 2.14% |
PGR | -7.16% | $149.10B | +57.29% | 0.45% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MNR | 0.02% | $1.66B | -10.71% | 15.90% |
TAK | 0.05% | $43.18B | -2.85% | 2.17% |
FAX | -0.08% | - | - | 3.80% |
SSSS | -0.12% | - | - | 0.00% |
CHD | -0.14% | $27.18B | +19.50% | 1.03% |
GORV | -0.15% | $12.75M | -84.80% | 0.00% |
MCD | 0.15% | $208.34B | +3.66% | 2.30% |
CB | 0.20% | $114.43B | +26.00% | 1.24% |
SPRU | -0.24% | $42.41M | -31.94% | 0.00% |
RCL | 0.26% | $63.10B | +123.86% | 0.17% |
MTG | 0.29% | $6.23B | +41.45% | 2.00% |
QNTM | -0.32% | $9.19M | -94.36% | 0.00% |
DMLP | -0.33% | $1.58B | +18.00% | 10.54% |
IRON | -0.34% | $1.77B | +15.07% | 0.00% |
IQ | -0.36% | $1.10B | -56.00% | 0.00% |
EXEL | -0.37% | $9.83B | +62.16% | 0.00% |
LW | 0.38% | $10.70B | -23.51% | 1.93% |
NHTC | 0.38% | $61.83M | +0.19% | 14.81% |
IREN | 0.39% | $1.96B | +262.72% | 0.00% |
COKE | -0.41% | $10.72B | +73.12% | 0.33% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CTRN | 31.68% | $153.27M | -29.99% | 0.00% |
ATXS | 31.59% | $550.23M | +114.29% | 0.00% |
GHM | 31.10% | $464.78M | +132.21% | 0.00% |
ZNTL | 27.00% | $213.08M | -71.11% | 0.00% |
APLS | 26.93% | $3.61B | -41.27% | 0.00% |
SUM | 26.59% | $8.50B | +41.20% | 0.00% |
BZH | 26.57% | $1.02B | +22.71% | 0.00% |
AEIS | 26.49% | $4.20B | +16.90% | 0.27% |
PRLB | 26.49% | $907.12M | +1.96% | 0.00% |
TFIN | 26.47% | $2.34B | +43.04% | 0.00% |
DOV | 26.46% | $27.26B | +43.51% | 1.03% |
SITE | 26.45% | $6.25B | -0.17% | 0.00% |
APOG | 26.36% | $1.78B | +75.93% | 1.23% |
AMG | 26.31% | $5.53B | +38.61% | 0.02% |
ABCL | 26.24% | $800.44M | -37.56% | 0.00% |
VMC | 26.18% | $36.71B | +32.49% | 0.66% |
AWI | 26.13% | $6.69B | +84.16% | 0.75% |
SKY | 26.12% | $5.67B | +68.31% | 0.00% |
MTX | 26.09% | $2.54B | +28.39% | 0.52% |
KAR | 26.03% | $2.09B | +31.90% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -19.01% | $378.68M | 1.43% |
TAIL | -15.70% | $67.98M | 0.59% |
VIXY | -15.55% | $195.31M | 0.85% |
IBTE | -12.57% | $1.68B | 0.07% |
OWNS | -11.00% | $124.26M | 0.3% |
WEAT | -9.34% | $122.51M | 0.28% |
EQLS | -9.12% | $17.58M | 1% |
AGZ | -8.71% | $709.14M | 0.2% |
HDRO | -8.07% | $164.26M | 0.3% |
TBIL | -7.27% | $4.38B | 0.15% |
TOTL | -7.25% | $3.31B | 0.55% |
XONE | -6.49% | $549.08M | 0.03% |
LGOV | -6.41% | $608.98M | 0.67% |
USDU | -6.24% | $200.96M | 0.5% |
UUP | -6.16% | $326.18M | 0.77% |
CANE | -6.12% | $18.13M | 0.29% |
LQDW | -6.04% | $207.20M | 0.34% |
CORN | -5.99% | $61.56M | 0.2% |
XBIL | -5.90% | $637.70M | 0.15% |
DFSD | -5.76% | $3.63B | 0.16% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBY | 0.06% | $127.69M | 0.99% |
JBBB | -0.08% | $1.26B | 0.49% |
IBTJ | 0.12% | $387.65M | 0.07% |
IBTF | 0.17% | $2.06B | 0.07% |
SCHO | -0.28% | $11.10B | 0.03% |
HYD | 0.31% | $3.19B | 0.32% |
SCHP | 0.32% | $11.70B | 0.03% |
BSJO | 0.38% | $466.18M | 0.43% |
CCOR | 0.39% | $109.04M | 1.18% |
GCOR | 0.41% | $394.20M | 0.14% |
TYA | 0.50% | $124.39M | 0.17% |
SEIX | -0.54% | $268.86M | 0.62% |
IBTH | 0.55% | $1.08B | 0.07% |
UNG | -0.76% | $918.08M | 1.06% |
UTWO | -0.80% | $447.63M | 0.15% |
DBA | -0.82% | $762.43M | 0.93% |
GOVZ | 0.83% | $313.23M | 0.1% |
SHYD | 0.87% | $311.72M | 0.35% |
VNLA | 0.97% | $2.27B | 0.23% |
SPTS | -1.00% | $5.70B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QQA | 33.67% | $134.59M | 0% |
RSPA | 32.44% | $272.59M | 0% |
IWC | 30.53% | $932.57M | 0.6% |
XHB | 29.69% | $2.10B | 0.35% |
IJT | 29.62% | $6.64B | 0.18% |
GSSC | 29.40% | $533.10M | 0.2% |
CALF | 29.38% | $8.93B | 0.59% |
SLYG | 29.32% | $3.69B | 0.15% |
IWO | 28.92% | $12.57B | 0.24% |
PRFZ | 28.90% | $2.62B | 0.39% |
VTWO | 28.88% | $12.48B | 0.1% |
SMLF | 28.86% | $1.44B | 0.15% |
PSC | 28.82% | $709.02M | 0.38% |
PHO | 28.80% | $2.26B | 0.59% |
IWM | 28.67% | $75.91B | 0.19% |
DFSV | 28.65% | $4.17B | 0.31% |
XRT | 28.61% | $436.77M | 0.35% |
VIOV | 28.52% | $1.44B | 0.15% |
FIW | 28.47% | $1.86B | 0.53% |
ISCG | 28.15% | $641.36M | 0.06% |